1.0
26 July 2024
Former employee, less than 1 year
Boston, MA
Recommend
CEO approval
Business outlook
Pros
committed staff, good science, friendly folks
Cons
Senior leaders were not interested in quality in clinical trials, rather focus was on timelines, pushed staff to breaking point...missed quality signals left and right. Quality dept was either ignored or left out of clinical dev meetings.